Elevated plasma concentration of vascular endothelial growth factor in cardiac myxoma

Journal of Thoracic and Cardiovascular Surgery

Volumn 122, Issue 1, 2001, Pages 193-194

  Bennett, Kenneth R ^a   Gu, Jian Wei ^a   Adair, Thomas H ^a   Heath, Bobby J ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CASE REPORT; CORONARY SINUS; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART MYXOMA; HUMAN; HUMAN TISSUE; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TUMOR VOLUME;

EID: 0035412841     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2001.113744     Document Type: Article

References (3)

1. Kono T, Koide N, Hama Y, Kitahara H, Nakano H, Suzuki J, et al. Expression of vascular endothelial growth factor and angiogenesis in cardiac myxoma: A study of fifteen patients. J Thorac Cardiovasc Surg. 2000;119:101-7.
2. Gu JW, Adair TH. Hypoxia-induced expression of VEGF is reversible in myocardial vascular smooth muscle cells. Am J Physiol. 1997;273:H628-33.
3. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, et al. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell. 1997;88:277-85.